Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT00609544
What this trial is testing

Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia

Who this might be right for
Chronic Kidney DiseaseAnemia
Regeneron Pharmaceuticals
Testing effectiveness (Phase 2)WithdrawnNCT05599815
What this trial is testing

Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Aldeyra Therapeutics, Inc.
Early research (Phase 1)Study completedNCT01372826
What this trial is testing

Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal Function

Who this might be right for
Renal Impairment
AstraZeneca 32
Testing effectiveness (Phase 2)Study completedNCT02021409
What this trial is testing

Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Bayer 126
Early research (Phase 1)Study completedNCT01901133
What this trial is testing

Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control Group

Who this might be right for
Pharmacokinetics of MDV3100Healthy SubjectsKidney Diseases
Astellas Pharma Europe B.V. 33
Testing effectiveness (Phase 2)Ended earlyNCT01439867
What this trial is testing

Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism

Who this might be right for
Chronic Kidney DiseaseHyperparathyroidism, Secondary
Amgen 18
Early research (Phase 1)Study completedNCT04908436
What this trial is testing

Learn How BAY94-8862 Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body in Adult Participants With Reduced Kidney Function and in Healthy Participants With Similar Age, Weight and Gender Distribution

Who this might be right for
Worsening Chronic Heart FailureChronic Kidney Disease
Bayer 33
Early research (Phase 1)Study completedNCT06672276
What this trial is testing

To Evaluate the Pharmacokinetics and Safety of TQD3606 for Injection in Subjects With Renal Insufficiency

Who this might be right for
Resistant to Gram-positive, Gram-negative and Anaerobic Bacteria
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 32
Large-scale testing (Phase 3)Study completedNCT00354458
What this trial is testing

PROTECT-2: A Study of the Selective A1 Adenosine Receptor Antagonist KW-3902 for Patients Hospitalized With Acute HF and Volume Overload to Assess Treatment Effect on Congestion and Renal Function

Who this might be right for
Heart Failure, Congestive
NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 1,102
Early research (Phase 1)Study completedNCT03161015
What this trial is testing

Single-Dose PK Study of GBT440 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Global Blood Therapeutics 16
Testing effectiveness (Phase 2)UnknownNCT04496596
What this trial is testing

Study of Suramin in Subjects With Furosemide-Resistant AKI

Who this might be right for
Acute Kidney Injury
Rediscovery Life Sciences 68
Large-scale testing (Phase 3)Study completedNCT00542386
What this trial is testing

MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia

Who this might be right for
Chronic Kidney DiseaseDialysisHyperphosphatemia+1 more
Tanabe Pharma Corporation 642
Early research (Phase 1)Study completedNCT03882762
What this trial is testing

A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol

Who this might be right for
Pharmacokinetic
Tris Pharma, Inc. 34
Early research (Phase 1)Study completedNCT04179630
What this trial is testing

Study of Aldafermin (NGM282) in Participants With Impaired Renal Function

Who this might be right for
Impaired Renal Function
NGM Biopharmaceuticals, Inc 48
Testing effectiveness (Phase 2)Study completedNCT00456053
What this trial is testing

Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin

Who this might be right for
Renal Anemia
Kyntra Bio 145
Large-scale testing (Phase 3)Study completedNCT01222884
What this trial is testing

A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D

Who this might be right for
Chronic Kidney Disease Stage 5 (Dialysis Dependent)
Pharmacosmos A/S 351
Testing effectiveness (Phase 2)Study completedNCT00210743
What this trial is testing

Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.

Who this might be right for
AnemiaKidney Diseases
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 67
Large-scale testing (Phase 3)Study completedNCT00925587
What this trial is testing

Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease

Who this might be right for
AnemiaChronic Kidney Disease
Amgen 358
Large-scale testing (Phase 3)Study completedNCT00416520
What this trial is testing

A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia

Who this might be right for
Chronic Kidney DiseaseHyperphosphatemia
Tanabe Pharma Corporation 336
Early research (Phase 1)Study completedNCT03172884
What this trial is testing

Study of Copanlisib in Hepatic or Renal Impairment

Who this might be right for
Hepatic Insufficiency, Renal Insufficiency
Bayer 30
Next Page